Stay updated on Aeterna Zentaris Press Releases
Sign up to get notified when there's something new on the Aeterna Zentaris Press Releases page.

Latest updates to the Aeterna Zentaris Press Releases page
- Check4 days agoChange DetectedThe webpage now includes an announcement from COSCIENS Biopharma Inc. regarding successful Phase 1 results for a new clinical trial, while the previous announcement about Aeterna Zentaris has been removed.SummaryDifference24%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoNo Change Detected
- Check83 days agoChange DetectedCOSCIENS Biopharma Inc. has provided a corporate update and highlighted its pipeline prioritization as of December 23, 2024, while the merger transaction between Aeterna Zentaris and Ceapro has been completed as of June 3, 2024.SummaryDifference12%
- Check119 days agoChange DetectedThe website has undergone significant changes with new additions, while the top and bottom sections have been removed.SummaryDifference3%
- Check126 days agoChange DetectedCOSCIENS Biopharma Inc. has reported its third quarter 2024 financial results and provided updates on its merger integration and development programs, while an update from Aeterna Zentaris regarding its annual meeting has been removed.SummaryDifference23%
- Check133 days agoChange DetectedNew sections have been added to the website, including a top of page and a bottom of page.SummaryDifference3%
- Check163 days agoChange DetectedCOSCIENS Biopharma has announced a change to its Board of Directors on October 8, 2024, while details regarding a transaction involving Aeterna Zentaris have been removed from the site.SummaryDifference12%
Stay in the know with updates to Aeterna Zentaris Press Releases
Enter your email address, and we'll notify you when there's something new on the Aeterna Zentaris Press Releases page.